Systems America, Inc. (SYAI) announced today after market hours that company received notice that Pink OTC Markets finished the processing the Company’s 2011 Annual Report and two reports for the quarters of 2012. As the result the Pink Sheets “Current Information” tier will be applied to the SYAI on July 25, 2012. Also Systems America is […]
Idenix Pharmaceuticals, Inc. (IDIX) yesterday after market close announced results from an ongoing phase IIb study of IDX184 in combination with pegylated interferon and ribavirin (PegIFN/RBV). Someone may be arguing about IDX184 efficacy judging by the number of trial patients that responded well to the initial treatment with a combination of IDX184, pegylated interferon, and […]
